Novel App Screens for Anemia without Blood Test
|
By HospiMedica International staff writers Posted on 27 Sep 2016 |

Image: The HemaApp measures hemoglobin levels by illuminating a finger with a smartphone’s camera flash (Photo courtesy of Dennis Wise / UW).
Hemoglobin levels and anemia can be construed non-invasively by illuminating a patient’s finger with a smartphone camera flash, according to a new study.
The HemaApp smartphone application, under development at the University of Washington (UW; Seattle, USA), shines light through a patient’s finger at different wavelengths, as well as infrared (IR) energy, to create a series of videos. By analyzing color absorption and reflectance across the different wavelengths, it detects concentrations of hemoglobin and other blood components, such as plasma. Processing algorithms also use pulse to distinguish between the properties of the patient’s blood and the physical characteristics of the finger.
The researchers tested the app under three different scenarios: using the smartphone camera’s flash alone, in combination with a common incandescent light bulb providing ambient light, and with a low-cost light emitting diode (LED) lighting attachment. The additional illumination sources are used to take advantage of properties found in other wavelengths of the electromagnetic spectrum that present useful absorption properties, but that are not currently found on all smartphone cameras.
In the initial trials, the correlation between HemaApp and the patient’s hemoglobin count on a complete blood count (CBC) test using the smartphone camera alone was 69%, with a common incandescent light bulb the correlation was 74%, and when used with the LED attachment, the correlation was 82%. For comparison, the Masimo (Irvine, CA, USA) Pronto showed a correlation of 81% to the CBC. The study was presented at the International Joint Conference on Pervasive and Ubiquitous Computing (UbiComp), held during September 2016 in Heidelberg (Germany).
“New phones are beginning to have more advanced infrared and multi-color LED capabilities; but what we found is that even if your phone doesn’t have all that, you can put your finger near an external light source like a common light bulb and boost the accuracy rates,” said senior author Professor Shwetak Patel, PhD, of the department of computer science & engineering and electrical engineering. “We’re just starting to scratch the surface here. There’s a lot that we want to tackle in using phones for non-invasively screening disease.”
Related Links:
University of Washington
Masimo
The HemaApp smartphone application, under development at the University of Washington (UW; Seattle, USA), shines light through a patient’s finger at different wavelengths, as well as infrared (IR) energy, to create a series of videos. By analyzing color absorption and reflectance across the different wavelengths, it detects concentrations of hemoglobin and other blood components, such as plasma. Processing algorithms also use pulse to distinguish between the properties of the patient’s blood and the physical characteristics of the finger.
The researchers tested the app under three different scenarios: using the smartphone camera’s flash alone, in combination with a common incandescent light bulb providing ambient light, and with a low-cost light emitting diode (LED) lighting attachment. The additional illumination sources are used to take advantage of properties found in other wavelengths of the electromagnetic spectrum that present useful absorption properties, but that are not currently found on all smartphone cameras.
In the initial trials, the correlation between HemaApp and the patient’s hemoglobin count on a complete blood count (CBC) test using the smartphone camera alone was 69%, with a common incandescent light bulb the correlation was 74%, and when used with the LED attachment, the correlation was 82%. For comparison, the Masimo (Irvine, CA, USA) Pronto showed a correlation of 81% to the CBC. The study was presented at the International Joint Conference on Pervasive and Ubiquitous Computing (UbiComp), held during September 2016 in Heidelberg (Germany).
“New phones are beginning to have more advanced infrared and multi-color LED capabilities; but what we found is that even if your phone doesn’t have all that, you can put your finger near an external light source like a common light bulb and boost the accuracy rates,” said senior author Professor Shwetak Patel, PhD, of the department of computer science & engineering and electrical engineering. “We’re just starting to scratch the surface here. There’s a lot that we want to tackle in using phones for non-invasively screening disease.”
Related Links:
University of Washington
Masimo
Latest Health IT News
- EHR Alerts Support Dosing, Sedation, and Shock Recognition in Cardiac Care
- Adaptive Radiation QA Software Gains Validation for NeoArc Treatments
- Healthcare Database Helps Close Long COVID Surveillance Gap
- Smartphone App Improves Blood Pressure Control in Hypertension
- New Tablet Platform Extends Stroke Neurorehabilitation Beyond the Clinic
- Registry-Driven Digital Outreach Boosts Use of Heart Failure Medicines
- Nurse-Coordinated Care Model Improves Heart Failure Outcomes
- Imaging Tool Quantifies Calcinosis Cutis Volume to Monitor Treatment
- Digital Symptom Monitoring Supports More Personalized Breast Cancer Care
- Short Digital Training Program Improves Motor Function in Parkinson’s Disease
- New Cloud Platform Streamlines Capsule Endoscopy Workflow and Reporting
- Smartwatch Monitoring Identifies Abnormal Vital Signs Before Routine Checks
- Weekly Remote Symptom Monitoring Improves Symptom Control in Advanced Cancer
- Digital Heart Model Supports Targeted Ablation in Atrial Fibrillation
- AI Framework Helps Clinicians Create Trustworthy Risk Prediction Tools
- AI Tool Screens for Primary Aldosteronism Using Routine EHR Data
Channels
Artificial Intelligence
view channel
AI Tool Predicts Long-Term Cardiovascular Risk from Sleep Study ECG
Sleep disorders such as insomnia and obstructive sleep apnea are established cardiovascular risk factors and are commonly evaluated with overnight polysomnography. These studies routinely record electrocardiogram... Read more
Predictive Model Supports Growth Hormone Treatment Planning in Idiopathic Short Stature
Idiopathic short stature (ISS) describes children whose height is substantially below the expected range for age and sex without an identifiable medical cause. Recombinant growth hormone therapy can support... Read moreSurgical Techniques
view channel
Tiny Robots Could Speed Targeted Drug Delivery to Heart Infections
Endocarditis is an infection of heart tissue that can become life-threatening when treatment fails to reach the infected site. About 50,000 people in the United States develop the condition each year.... Read more
Contact Radiotherapy Offers New Organ-Preserving Approach for Rectal Cancer
Tampere University Hospital, known as Tays, is the first hospital in Finland to introduce contact radiotherapy for rectal cancer using high-dose-rate brachytherapy, or HDR brachytherapy.... Read morePatient Care
view channel
AI Platform Personalizes Support Between Visits for Cancer Survivors
Cancer survivors often manage persistent side effects after treatment, including fatigue, anxiety, uncertainty, symptoms, stress, and questions between appointments. Clinical teams need ways to maintain... Read more
At-Home Neuromodulation Shows Promise in Selected Patients With Hypertension
High blood pressure is a major risk factor for cardiovascular disease, including heart attack and stroke. Many patients receiving treatment for hypertension still remain above recommended blood pressure... Read more
EHR Model Flags High-Risk Periods in Patients with Metastatic Breast Cancer
Determining when patients with metastatic breast cancer are nearing the end of life remains difficult, often leading to intensive interventions with limited benefit. Prognostic uncertainty can delay goals-of-care... Read moreMedical Imaging
view channel
Public Chest CT Dataset Supports Explainable AI in Diagnostic Radiology
Chest computed tomography scans generate complex three-dimensional images that can be difficult for artificial intelligence systems to explain clearly. Clinicians need to verify AI findings before using... Read more
PSMA PET/CT-Guided Biopsy Improves Detection of Significant Prostate Cancer After Nondiagnostic MRI
Prostate cancer can be difficult to detect when magnetic resonance imaging (MRI) findings are negative or inconclusive. Men with persistent clinical risk factors may still require biopsy, yet standard... Read more
AI Software Detects Osteoporosis from Routine CT Scans
Osteoporosis can progress for years without pain, leaving bone loss undetected until a fracture or back pain prompts testing. By that point, bone loss may already be advanced. Bone density testing is not... Read more
AI Model Uses Pretreatment CT Scans to Predict Immunotherapy-Related Pneumonitis Risk
Pneumonitis is a potentially life-threatening form of lung inflammation that affects about 10% of patients with lung cancer receiving immunotherapy. Because it can be difficult to predict before symptoms... Read moreHealth IT
view channel
EHR Alerts Support Dosing, Sedation, and Shock Recognition in Cardiac Care
Electronic health record alerts can add to clinician workload when they are poorly targeted. In critical cardiac care, however, delayed decisions can affect treatment timing, sedation exposure, and escalation... Read more
Adaptive Radiation QA Software Gains Validation for NeoArc Treatments
Adaptive radiation therapy allows clinicians to adjust treatment plans to daily anatomical changes such as tumor shrinkage, weight loss, or organ movement, improving precision while limiting exposure to... Read morePoint of Care
view channel
Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes
Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more
Microneedle Patch Enables At-Home Monitoring of Acute Kidney Injury
Kidney disease is often silent in its early stages, making timely detection difficult outside clinical settings. Early biomarkers such as neutrophil gelatinase–associated lipocalin can require blood draws... Read moreBusiness
view channel
Terumo Neuro Acquisition Advances Liquid Embolic Technology for Chronic Subdural Hematoma
Terumo Neuro (Aliso Viejo, CA, USA) signed an agreement to acquire Arsenal Medical Inc. (Waltham, MA, USA), a privately held, clinical-stage biomaterials company. The proposed acquisition would add NeoCast,... Read moreWorld Health Expo to Showcase Trillion-Dollar Growth Across Pharma, Biotech, Longevity and Wellness at 2027 Edition
World Health Expo (WHX) expands with the new Pharma, Biotech, Longevity and Wellness industry sectors More than 235,000 professional visits, over 4,200 exhibitors and representatives from over... Read more
Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery
As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more







